Publications by authors named "Craig Devoe"

Claim this Profile
L
Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results.
Zev A Wainberg, Colin D Weekes, Muhammad Furqan, Pashtoon M Kasi, Craig E Devoe

Nat Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.
Jennifer J Knox, Grainne O'Kane, Daniel King, Daniel Laheru, Amber N Habowski, Craig E Devoe

J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.
Jennifer J Knox, Grainne O'Kane, Daniel King, Daniel Laheru, Amber N Habowski, Craig E Devoe

J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Peritoneal Metastasis in Patients with Pancreatic Ductal Adenocarcinoma.
Grace Wu, Oliver J Standring, Daniel A King, Sepideh Gholami, Craig E Devoe

Curr Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing gastrointestinal stromal tumor outcomes between geriatric and non-geriatric patients: A population-based analysis.
Abhiram Singh, Bhargava Chitti, Christopher Aguiar, A Gabriella Wernicke, Craig E Devoe

World J Surg· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updates in the Management of Uveal Melanoma.
Mali Barbi, Richard D Carvajal, Craig E Devoe

Cancer J· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial.
Shubham Pant, Zev A Wainberg, Colin D Weekes, Muhammad Furqan, Pashtoon M Kasi, Craig E Devoe

Nat Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inpatient utilization of immune checkpoint inhibitors and clinical outcomes.
Jonathan Wang, Chung-Shien Lee, Shirin Attarian, Nina Kohn, Craig Devoe

J Oncol Pharm Pract· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diversifying Eligibility to Enhance Real-World Results.
Fatima Fayyaz, Richard D Carvajal, Craig E Devoe

J Clin Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
Sapna P Patel, Megan Othus, Yuanbin Chen, G Paul Wright, Kathleen J Yost, Craig E Devoe

N Engl J Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pharmacokinetics of therapeutic arsenic trioxide in acute promyelocytic leukemia patients.
Cristina M Ghiuzeli, Miroslav Stýblo, Jesse Saunders, Anthony Calabro, Daniel Budman, Craig Devoe

Leuk Lymphoma· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of the ATR inhibitor berzosertib in combination with cisplatin in patients with advanced solid tumours.
Geoffrey I Shapiro, Robert Wesolowski, Craig Devoe, Simon Lord, John Pollard

Br J Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant.
Naoka Murakami, Patrick Mulvaney, Melissa Danesh, Ala Abudayyeh, Adi Diab, Craig E Devoe

Kidney Int· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of NY-ESO-1 vaccine + anti-CTLA4 antibody Ipilimumab (IPI) in patients with unresectable or metastatic melanoma.
Craig L Slingluff, Hassane M Zarour, Hussein Abdul-Hassan Tawbi, John M Kirkwood, Michael A Postow, Craig E Devoe

Oncoimmunology· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simple parameters to solve a complex issue: predicting response to checkpoint inhibitor therapy in lung cancer.
James Newman, Isabel Preeshagul, Nina Kohn, Craig Devoe, Nagashree Seetharamu

Lung Cancer Manag· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment nutritional status and response to checkpoint inhibitors in lung cancer.
Chung-Shien Lee, Craig E Devoe, Xinhua Zhu, Joanna Stein Fishbein, Nagashree Seetharamu

Lung Cancer Manag· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why HALO 301 Failed and Implications for Treatment of Pancreatic Cancer.
Nausheen Hakim, Rajvi Patel, Craig Devoe, Muhammad W Saif

Pancreas (Fairfax)· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excellent Response to Nivolumab and Ipilimumab in Metastatic Gastroesophageal Junction Squamous Carcinoma.
Narayanan Sadagopan, Craig Devoe

Case Rep Oncol Med· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer.
Hervé Tiriac, Pascal Belleau, Dannielle D Engle, Dennis Plenker, Astrid Deschênes, Craig Devoe

Cancer Discov· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or Anus.
Alexa B Schrock, Dean Pavlick, Samuel J Klempner, Jon H Chung, Brady Forcier, Craig Devoe

Clin Cancer Res· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review.
Rimda Wanchoo, Sabine Karam, Nupur N Uppal, Valerie S Barta, Gilbert Deray, Craig Devoe

Am J Nephrol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Profiling of Small-Bowel Adenocarcinoma.
Alexa B Schrock, Craig E Devoe, Robert McWilliams, James Sun, Thomas Aparicio

JAMA Oncol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential development of two separate therapy-related myeloid neoplasms following radiotherapy for prostate cancer.
Gabor Oroszi, Judith Brody, Tianyu Yang, Steven L Allen, Craig Devoe

Leuk Lymphoma· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemia.
Amir T Fathi, Daniel J DeAngelo, Kristen E Stevenson, Jonathan E Kolitz, Julie D Asch, Craig E Devoe

Cancer· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF inhibitors - do we need to worry about kidney injury?
Rimda Wanchoo, Craig Devoe, Kenar D Jhaveri

Expert Opin Drug Saf· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis